Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 161 Nivolumab 133 Ipilimumab 78 Cyclophosphamide 47 Specimen Handling 43 Magnetic Resonance Spectroscopy 39 cemiplimab 35 Biopsy 31 fludarabine 29 trametinib 24 relatlimab 24 binimetinib 23 Interleukin-2 22 fludarabine phosphate 21 dabrafenib 20 atezolizumab 19 Radiotherapy 19 Opdualag 19 aldesleukin 18 Radiosurgery 18 CTLA-4 Antigen 18 encorafenib 17 Blood Specimen Collection 17 avelumab 14 Immunoglobulin G 14 Disulfides 13 lifileucel 11 lenvatinib 11 Bevacizumab 11 Paclitaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

gadopiclenol × Dermatologic × 1 year × Clear all

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡